Chronic Thromboembolic Pulmonary Hypertension: What Is
It, Symptoms, and Treatment
In this article, we will examine the details of chronic
thromboembolic pulmonary hypertension (CTEPH). CTEPH is high blood pressure in
the small blood vessels of the lungs caused by blood clots and scar tissue.
While it can affect anyone, CTEPH is often curable.
What Is Chronic Thromboembolic Pulmonary Hypertension?
CTEPH is a rare form of pulmonary hypertension characterized by abnormally high
pressure in the small blood vessels of the lungs. This elevated pressure stems
from previous blood clots that formed in the lungs.
Who Gets CTEPH? CTEPH occurs exclusively in
individuals with a history of blood clots in the lungs (pulmonary embolism).
High pressure in the lung vessels without a prior pulmonary embolism indicates
a different medical condition.
How Common Is CTEPH? The estimated annual incidence
in the general population is 3 to 30 new cases per million, with a prevalence
of 25 to 38 cases per million. However, because the condition is frequently
underdiagnosed or misdiagnosed, actual numbers are believed to be higher.
How Does CTEPH Affect the Body? In CTEPH, pressure
rises on the right side of the heart, causing oxygen-depleted blood to back up.
As a result, the heart must work harder to pump blood through the lungs, and
transit time through pulmonary vessels increases, leading to lower oxygen levels.
Causes of CTEPH CTEPH develops when small blood clots
in the pulmonary arteries fail to dissolve, eventually forming scar-like tissue
that narrows the blood vessels. Greater narrowing leads to higher vascular
pressure.
Risk Factors
- Having
a non-O blood type
- Bone
infection (osteomyelitis)
- Certain
types of cancer
- Chronic
gastrointestinal diseases, such as inflammatory bowel disease
- Female
sex
- Infection
of heart tissue related to a pacemaker
- Personal
or family history of blood clots or clotting disorders, including
antiphospholipid syndrome
- Previous
surgical removal of the spleen (splenectomy)
- Thyroid
hormone replacement therapy
Symptoms of CTEPH
- Chest
pain or tightness
- Coughing
up blood (hemoptysis; rare)
- Bluish
discoloration of the fingers and toes (cyanosis)
- Dizziness
or lightheadedness
- Fainting
(syncope)
- Fatigue
- Heart
palpitations
- Shortness
of breath (dyspnea), particularly during physical activity
- Swelling
in the legs due to fluid retention (edema)
Diagnosis Diagnostic evaluation typically begins with
screening tests, including:
- Ventilation-perfusion
(V/Q) lung scan
- Pulmonary
angiography (to visualize blood clots or narrowed vessels)
- Pulmonary
function tests
- Transthoracic
echocardiogram (TTE)
Additional tests are usually required to confirm the
diagnosis and assess disease severity:
- Right
heart catheterization
- CT
pulmonary angiography or digital subtraction angiography
- Magnetic
resonance imaging (MRI)
- Exercise
stress testing
Interventional Treatments Primary treatment requires
interventional procedures:
- Pulmonary
Endarterectomy (PEA): An open surgical procedure that removes blood
clots and scar tissue from the pulmonary arteries.
- Balloon
Pulmonary Angioplasty (BPA): A catheter-based procedure using tiny
balloons to push scar tissue aside and open narrowed arteries.
Medical Management Riociguat tablets may help
alleviate symptoms in individuals who are not candidates for surgery or
catheter interventions, or in those with persistent pulmonary hypertension
following surgical treatment.
Prognosis Pulmonary endarterectomy and balloon
pulmonary angiography can potentially cure CTEPH, offering an excellent
long-term prognosis. Because anxiety and depression are common—especially among
those unable to undergo curative interventions—patients are encouraged to
discuss mental health concerns with their doctor.
Prevention and Management While many underlying risk
factors are beyond individual control, avoiding tobacco use and quitting
smoking can support overall lung health.
Living with CTEPH requires lifelong blood thinner
(anticoagulant) therapy. Patients taking warfarin may need to manage their
intake of vitamin K–rich foods, such as soy and broccoli. Light exercise, such
as walking or structured pulmonary rehabilitation under medical supervision,
can help improve strength and overall well-being.
CTEPH is a rare but treatable form of pulmonary
hypertension. With timely interventional treatment, many patients achieve full
recovery and excellent outcomes.Would you like to discuss the procedural
details or eligibility criteria for pulmonary endarterectomy (PEA) versus
balloon pulmonary angioplasty (BPA)?
Ask Our Experts
Fill out the form below to ask our experts a question.
